WO2009084020A3 - Topical composition comprising halobetasol and salicylic acid - Google Patents

Topical composition comprising halobetasol and salicylic acid Download PDF

Info

Publication number
WO2009084020A3
WO2009084020A3 PCT/IN2008/000670 IN2008000670W WO2009084020A3 WO 2009084020 A3 WO2009084020 A3 WO 2009084020A3 IN 2008000670 W IN2008000670 W IN 2008000670W WO 2009084020 A3 WO2009084020 A3 WO 2009084020A3
Authority
WO
WIPO (PCT)
Prior art keywords
halobetasol
salicylic acid
topical composition
relates
present
Prior art date
Application number
PCT/IN2008/000670
Other languages
French (fr)
Other versions
WO2009084020A2 (en
Inventor
Ulhas Rameshchandra Dhuppad
Vasant Sitaram Khachane
Nitin Babulal Bhamre
Akhilesh Dayanand Sharma
Original Assignee
Glenmark Pharmaceuticals Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glenmark Pharmaceuticals Limited filed Critical Glenmark Pharmaceuticals Limited
Publication of WO2009084020A2 publication Critical patent/WO2009084020A2/en
Publication of WO2009084020A3 publication Critical patent/WO2009084020A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Abstract

The present invention relates to topical pharmaceutical compositions, their uses an methods of manufacturing. Specifically, the present invention relates to topical composition comprising combination of halobetasol and salicylic acid.
PCT/IN2008/000670 2007-10-18 2008-10-15 Topical composition comprising halobetasol and salicylic acid WO2009084020A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2074/MUM/2007 2007-10-18
IN2074MU2007 2007-10-18

Publications (2)

Publication Number Publication Date
WO2009084020A2 WO2009084020A2 (en) 2009-07-09
WO2009084020A3 true WO2009084020A3 (en) 2009-12-10

Family

ID=40824836

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2008/000670 WO2009084020A2 (en) 2007-10-18 2008-10-15 Topical composition comprising halobetasol and salicylic acid

Country Status (2)

Country Link
BR (1) BRPI0805005A2 (en)
WO (1) WO2009084020A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8809307B2 (en) 2010-11-22 2014-08-19 Dow Pharmaceutical Sciences, Inc. Pharmaceutical formulations containing corticosteroids for topical administration
US11957753B2 (en) 2010-11-22 2024-04-16 Bausch Health Ireland Limited Pharmaceutical formulations containing corticosteroids for topical administration
ES2812451T3 (en) 2015-06-18 2021-03-17 Bausch Health Ireland Ltd Topical compositions comprising a corticosteroid and a retinoid to treat psoriasis

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999049835A1 (en) * 1998-03-31 1999-10-07 Johnson And Johnson Consumer Companies, Inc. An acidified composition for topical treatment of nail and skin conditions
EP1332758A1 (en) * 2002-01-17 2003-08-06 Rifkin, Bruce Dermatological compositions comprising a corticosteroid and zinc pyrithione
US20040241099A1 (en) * 2003-05-28 2004-12-02 Popp Karl F. Foamable pharmaceutical compositions and methods for treating a disorder

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999049835A1 (en) * 1998-03-31 1999-10-07 Johnson And Johnson Consumer Companies, Inc. An acidified composition for topical treatment of nail and skin conditions
EP1332758A1 (en) * 2002-01-17 2003-08-06 Rifkin, Bruce Dermatological compositions comprising a corticosteroid and zinc pyrithione
US20040241099A1 (en) * 2003-05-28 2004-12-02 Popp Karl F. Foamable pharmaceutical compositions and methods for treating a disorder

Also Published As

Publication number Publication date
WO2009084020A2 (en) 2009-07-09
BRPI0805005A2 (en) 2009-08-25

Similar Documents

Publication Publication Date Title
WO2012042371A3 (en) Pharmaceutical composition
IL204621A0 (en) Bicyclic - ?? - amino acid derivatives, compositions comprising the same and uses thereof
WO2008132229A3 (en) Highly concentrated insulin solutions and compositions
WO2012061290A3 (en) Pesticidal compositions and processes related thereto
WO2012088266A3 (en) Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
WO2010000877A3 (en) Formulation with irritation reducing action comprising bisabolol and [6]-paradol
WO2010030598A3 (en) Pharmaceutical formulations comprising pemetrexed
WO2012170889A8 (en) Cleavable lipids
IL219865A0 (en) Acid salt forms of polymer-drug conjugates, compositions comprising the same, methods of producing the same and uses thereof
WO2008089087A3 (en) Tablet-in-tablet compositions
WO2012068441A3 (en) Intedanib salts and solid state forms thereof
WO2007095339A3 (en) Methods of manufacturing corticosteroid solutions
WO2010043717A3 (en) Pharmaceutical topical compositions
IL210549A (en) Substituted- quinoxaline-type bridged-piperidine compounds, compositions comprising them and uses thereof for the manufacture of medicaments
WO2010049454A3 (en) Antimicrobial composition from copepods
WO2009115084A3 (en) Pyrrolopyrimidine derivatives, and use thereof
WO2010141694A3 (en) Borinic compositions
WO2010092088A3 (en) Use of hydrophobin as a spreading agent
WO2008142569A3 (en) Topical compositions containing magaldrate
WO2011054741A3 (en) Crystalline complexes of 4-hydroxy benzoic acid and selected pesticides
WO2009146202A3 (en) Transketalized compositions, synthesis, and applications
WO2008154234A3 (en) Extended release formulation of nevirapine
IN2012DN00239A (en)
WO2008073863A3 (en) Preparation and utility of substituted allylamines
WO2012075015A3 (en) Oral metronidazole pharmaceutical compositions

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08867935

Country of ref document: EP

Kind code of ref document: A2